Affiliation:
1. From the Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (Z.A.A., E.G., H.R.K.); Department of Microbiology, University of Maryland (S.K.), College Park, Md; and Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Università di Milano (Italy) (F.P.).
Abstract
Abstract
Congestive heart failure is characterized by avid sodium retention and a blunted renal response to exogenous and endogenous atrial natriuretic peptide. Inhibition of neutral endopeptidase EC
3.4.24.11
, the main enzyme that degrades natriuretic peptides, produces a natriuretic response in different models of congestive heart failure. This raises the possibility that an increase in either the expression or activity of neutral endopeptidase is responsible for these phenomena. In the present study, we examined (1) the renal effects of SQ-28,603, a neutral endopeptidase inhibitor, in rats with moderate and severe congestive heart failure induced by an aortocaval fistula compared with sham controls, and (2) neutral endopeptidase expression and activity in the lungs and kidneys of these rats. Infusion of SQ-28,603 (40 mg/kg IV) induced a significant natriuretic response in normal rats and rats with moderate congestive heart failure. This response was blunted in rats with severe congestive heart failure. Surprisingly, renal neutral endopeptidase mRNA levels, assessed by quantitative reverse transcriptase–polymerase chain reaction; protein levels, assessed by Western blotting; and activity, assessed by gelatin gels, were comparable in all groups. Pulmonary neutral endopeptidase mRNA levels decreased by 45% in rats with severe congestive heart failure but not in rats with mild congestive heart failure. In addition, pulmonary neutral endopeptidase immunoreactivity levels and activity were significantly decreased in congestive heart failure in correlation with the severity of the disorder. We conclude that an increase in neutral endopeptidase expression or activity does not occur in rats with congestive heart failure, and therefore, an upregulation of neutral endopeptidase is unlikely to account for the blunted natriuretic response to the atrial natriuretic peptide and the positive sodium balance in congestive heart failure.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference44 articles.
1. The Kidney in Heart Failure
2. Renal and circulatory mechanisms in congestive heart failure
3. Hormones in heart failure--regulation and counterregulation
4. The Neurohumoral Axis in Congestive Heart Failure
5. Clavell A Stingo A Margulies K Lerman A Underwood D Burnett JC. Physiological significance of endothelin: its role in congestive heart failure. Circulation . 1993;87(suppl V):V-45-V-50.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献